New Published Real-World Evidence Shows KidneyIntelX™ Utility

Posted on

Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple Physician Specialties KidneyIntelX individualizes clinical decisions beginning at primary care where impacts of new therapies, blood pressure strategies and timely referral can have maximal effect on outcomes and cost in patients with type 2 diabetes and chronic kidney disease LONDON […]

Read More

Metrodora raises $35M to address neuroimmune disease

Posted on

Originally published in Axios Pro   Instacart CEO Fidji Simo waited three years to be diagnosed with POTS, the condition that led her to cofound the Metrodora Institute, a new outpatient clinical center she’s unveiling with $35 million in corporate venture backing. Why it matters: POTS — postural orthostatic tachycardia syndrome — falls into a […]

Read More

Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Posted on

Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of Intermountain Health, are now certified to offer solid tumor testing to […]

Read More

Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Posted on

Metrodora is the first integrated, multidisciplinary medical and research center dedicated to diagnosing and treating neuroimmune axis disorders, an under-researched disease space that impacts hundreds of millions of people Institute is building the world’s first biobank and high-density data repository focused on these conditions to inform treatment and serve as the bedrock for future research […]

Read More

bioMérieux receives US FDA 510(k) clearance for the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and will apply for CLIA-waiver

Posted on

Marcy-l’Étoile (France), April 13, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the fast and accurate multiplex PCR*-based BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini. bioMérieux will immediately apply for Clinical Laboratory Improvement Amendments (CLIA) waiver for the test. The […]

Read More

PEEL THERAPEUTICS DESCRIBES EXCESSIVE NETOSIS INDUCTION IN LONG COVID

Posted on

Peer-reviewed study offers first description of ongoing NETosis induction in Long COVID; provides insights into pathogenesis and can serve as a surrogate marker for persistent pathology Research emphasizes need to explore neutrophil-targeted therapies in acute and chronic COVID-19 SALT LAKE CITY – April 13, 2023 – Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced research […]

Read More

NEW DOMESTIC SUPPLY SOURCE TO HELP ADDRESS CRITICAL SHORTAGE OF MEDICAL RADIOISOTOPES

Posted on

PROPRIETARY PLATFORM WILL BE CAPABLE OF GENERATING UP TO 12 DIFFERENT RARE ISOTOPES SIMULTANEOUSLY WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, announced its state-of-the-art facility will open in the first quarter of 2025 in West Valley City, Utah. The 170,000 square foot production […]

Read More

Bench to Bedside 2023 Competition

Posted on

Date & Time: April 17th, 2023 | 6:00p – 8:30p Location: Utah State Capitol Building RSVP & Agenda:  bit.ly/b2b-comp-night-2023 On April 17th, join us at the Utah State Capitol Building for the 13th annual Bench to Bedside Competition Night!  Over the course of the school year, 27 student teams from universities across have come together […]

Read More

BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

Posted on

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal […]

Read More

Nelson Labs® Receives ASCA Accreditation from the U.S. FDA

Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries, announced this week that it is now an ASCA-accredited testing laboratory by the U.S. Food and Drug Administration (FDA) within the category of biocompatibility. ASCA is an accreditation structure of the FDA, wherein accreditation […]

Read More

Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

In a clinical decision effectiveness study, KidneyIntelX classified more Black vs non-Black patients as high risk for progression of chronic kidney disease, resulting in increased prescription of SGLT2-inhibitor drug therapy Additional study results illustrate how KidneyIntelX is aligned with the Veteran’s Health Administration care practice guidelines for risk assessment in early-stage kidney disease and the introduction […]

Read More

ARUP Laboratories Chooses Gestalt’s PathFlow® Solution for Its Strategic Digital Initiatives

Posted on

SPOKANE, WASHINGTON, and SALT LAKE CITY (April 12, 2023)—Gestalt Diagnostics Inc., a leading provider of artificial intelligence (AI)-powered digital pathology solutions, and ARUP Laboratories, a national academic reference laboratory with hospital and health system clients in all 50 states, today announced that ARUP has selected Gestalt’s award-winning PathFlow® digital platform as the solution to support […]

Read More